Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

C Martínez
C Canals
B Sarina
EP Alessandrino
D Karakasis
A Pulsoni
S Sica
M Trneny
JA Snowden
E Kanfer
N Milpied
A Bosi
S Guidi
CA de Souza
R Willemze
R Arranz
L Jebavy
A Hellmann
D Sibon
R Oneto
JJ Luan
P Dreger
L Castagna
A Sureda

January 2013

Background: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the st...

326 American Society of Hematology Management of Hodgkin Lymphoma in Relapse after Autologous Stem Cell Transplant

Michael Crump

August 2015

about 50 % of patients after autologous stem cell transplantation (ASCT), usually within the first y...

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma

Broeckelmann, P. J.
Mueller, H.
Casasnovas, O.
Hutchings, M.
von Tresckow, B.
Jurgens, M.
McCall, S. J.
Morschhauser, F.
Fuchs, M.
Borchmann, P.
Moskowitz, C. H.
Engert, A.

January 2017

Background: Novel agents are changing the treatment of relapsed or refractory Hodgkin lymphoma (HL)....

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.

Bröckelmann, P. J.
Müller, H.
Casasnovas, O.
Hutchings, M
von Tresckow, B.
Jürgens, M
Mccall, S. J.
Morschhauser, F.
Fuchs, M
Borchmann, P
Moskowitz, C. H.
Engert, A

June 2017

IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Chan, Fong Chun
Mottok, Anja
Gerrie, Alina S.
Power, Maryse
Nijland, Marcel
Diepstra, Arjan
van den Berg, Anke
Kamper, Peter
d'Amore, Francesco
d'Amore, Alexander Lindholm
Hamilton-Dutoit, Stephen
Savage, Kerry J.
Shah, Sohrab P.
Connors, Joseph M.
Gascoyne, Randy D.
Scott, David W.
Steidl, Christian

November 2017

Purpose: Our aim was to capture the biology of classical Hodgkin lymphoma (cHL) at the time of relap...

Outcomes of Hodgkin’s Lymphoma Patients with Relapse or Progression following Autologous Hematopoietic Cell Transplantation

Kaloyannidis, Panayotis
Voutiadou, Georgia
Baltadakis, Ioannis
Tsirigotis, Panagiotis
Spyridonidis, Alexandros
Repousis, Panagiotis
Balta, Artemisia
Tsimberis, Simeon
Karakasis, Dimitrios
Sakellari, Ioanna
Dervenoulas, Ioannis
Harhalakis, Nicholas
Anagnostopoulos, Achilles

March 2012

Patients with relapsed/progressed Hodgkin’s lymphoma (HL) following autologous hematopoietic cell tr...

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes

Engelhardt, Brian G
Holland, Derek W
Brandt, Stephen J
Chinratanalab, Wichai
Goodman, Stacey A
Greer, John P
Jagasia, Madan H
Kassim, Adetola A
Morgan, David S
Ruffner, Katherine L
Schuening, Friedrich G
Wolff, Steven
Bitting, Rhonda
Sulur, Paulgun
Stein, Richard S

January 2007

Between January 1990 and April 2001, 115 patients received high-dose chemotherapy (HDT) followed by ...

Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT.

Martínez, Carmen
Boumendil, Ariane
Romejko-Jarosinska, Joanna
Anagnostopoulos, Achilles
Faber, Edgar
Poire, Xavier
Yakoub-Agha, Ibrahim
Akhtar, Saad
Gurman, Gunhan
Pavone, Vincenzo
Halaburda, Kazimierz
Sousa, Aida Botelho
Ghesquières, Hervé
Finel, Hervé
Khvedelidze, Irma
Montoto, Silvia
Sureda, Anna

January 2020

The purpose of this study was to analyze the results of second autologous hematopoietic stem cell tr...

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

Robinson, Stephen P.
Sureda, Anna
Canals, Carmen
Russell, Nigel
Caballero, Dolores
Bacigalupo, Andrea
Iriondo, Arturo
Cook, Gordon
Pettitt, Andrew
Socie, Gerard
Bonifazi, Francesca
Bosi, Alberto
Michallet, Mauricette
Liakopoulou, Effie
Maertens, Johan
Passweg, Jakob
Clarke, Fiona
Martino, Rodrigo
Schmitz, Norbert

January 2009

BACKGROUND: The role of reduced intensity conditioning allogeneic stem transplantation (RICalloSCT) ...

The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years

Tanase, Alina
Akhtar, Saad
Ben Othman, Tarek
Ma'koseh, Mohammad
Bazarbachi, Ali
Boumendil, Ariane
Finel, Herve
Khvedelidze, Irma
Romejko-Jarosinska, Joanna
Afanasyev, Boris
Cheikh, Jean
Briones, Javier
Gulbas, Zafer
Hamladji, Rose-Marie
ELVERDİ, TUĞRUL
Blaise, Didier
Martinez, Carmen
Alma, Eleonora
Halaburda, Kazimierz
Sousa, Aida Botelho
Glass, Bertram
Robinson, Steven
Montoto, Silvia
Sureda, Anna

July 2022

Hodgkin lymphoma (HL) patients who relapse after autologous-stem-cell- transplantation (auto-SCT) ha...

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

C Martínez
C Canals
B Sarina
EP Alessandrino
D Karakasis
A Pulsoni
S Sica
M Trneny
JA Snowden
E Kanfer
N Milpied
A Bosi
S Guidi
CA de Souza
R Willemze
R Arranz
L Jebavy
A Hellmann
D Sibon
R Oneto
JJ Luan
P Dreger
L Castagna
A Sureda

January 2013

Background: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the st...

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma

Broeckelmann, P. J.
Mueller, H.
Casasnovas, O.
Hutchings, M.
von Tresckow, B.
Jurgens, M.
McCall, S. J.
Morschhauser, F.
Fuchs, M.
Borchmann, P.
Moskowitz, C. H.
Engert, A.

January 2017

Background: Novel agents are changing the treatment of relapsed or refractory Hodgkin lymphoma (HL)....

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.

Bröckelmann, P. J.
Müller, H.
Casasnovas, O.
Hutchings, M
von Tresckow, B.
Jürgens, M
Mccall, S. J.
Morschhauser, F.
Fuchs, M
Borchmann, P
Moskowitz, C. H.
Engert, A

June 2017

IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...

Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Chan, Fong Chun
Mottok, Anja
Gerrie, Alina S.
Power, Maryse
Nijland, Marcel
Diepstra, Arjan
van den Berg, Anke
Kamper, Peter
d'Amore, Francesco
d'Amore, Alexander Lindholm
Hamilton-Dutoit, Stephen
Savage, Kerry J.
Shah, Sohrab P.
Connors, Joseph M.
Gascoyne, Randy D.
Scott, David W.
Steidl, Christian

November 2017

Purpose: Our aim was to capture the biology of classical Hodgkin lymphoma (cHL) at the time of relap...

Outcomes of Hodgkin’s Lymphoma Patients with Relapse or Progression following Autologous Hematopoietic Cell Transplantation

Kaloyannidis, Panayotis
Voutiadou, Georgia
Baltadakis, Ioannis
Tsirigotis, Panagiotis
Spyridonidis, Alexandros
Repousis, Panagiotis
Balta, Artemisia
Tsimberis, Simeon
Karakasis, Dimitrios
Sakellari, Ioanna
Dervenoulas, Ioannis
Harhalakis, Nicholas
Anagnostopoulos, Achilles

March 2012

Patients with relapsed/progressed Hodgkin’s lymphoma (HL) following autologous hematopoietic cell tr...

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes

Engelhardt, Brian G
Holland, Derek W
Brandt, Stephen J
Chinratanalab, Wichai
Goodman, Stacey A
Greer, John P
Jagasia, Madan H
Kassim, Adetola A
Morgan, David S
Ruffner, Katherine L
Schuening, Friedrich G
Wolff, Steven
Bitting, Rhonda
Sulur, Paulgun
Stein, Richard S

January 2007

Between January 1990 and April 2001, 115 patients received high-dose chemotherapy (HDT) followed by ...

Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT.

Martínez, Carmen
Boumendil, Ariane
Romejko-Jarosinska, Joanna
Anagnostopoulos, Achilles
Faber, Edgar
Poire, Xavier
Yakoub-Agha, Ibrahim
Akhtar, Saad
Gurman, Gunhan
Pavone, Vincenzo
Halaburda, Kazimierz
Sousa, Aida Botelho
Ghesquières, Hervé
Finel, Hervé
Khvedelidze, Irma
Montoto, Silvia
Sureda, Anna

January 2020

The purpose of this study was to analyze the results of second autologous hematopoietic stem cell tr...

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

Robinson, Stephen P.
Sureda, Anna
Canals, Carmen
Russell, Nigel
Caballero, Dolores
Bacigalupo, Andrea
Iriondo, Arturo
Cook, Gordon
Pettitt, Andrew
Socie, Gerard
Bonifazi, Francesca
Bosi, Alberto
Michallet, Mauricette
Liakopoulou, Effie
Maertens, Johan
Passweg, Jakob
Clarke, Fiona
Martino, Rodrigo
Schmitz, Norbert

January 2009

BACKGROUND: The role of reduced intensity conditioning allogeneic stem transplantation (RICalloSCT) ...

The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years

Tanase, Alina
Akhtar, Saad
Ben Othman, Tarek
Ma'koseh, Mohammad
Bazarbachi, Ali
Boumendil, Ariane
Finel, Herve
Khvedelidze, Irma
Romejko-Jarosinska, Joanna
Afanasyev, Boris
Cheikh, Jean
Briones, Javier
Gulbas, Zafer
Hamladji, Rose-Marie
ELVERDİ, TUĞRUL
Blaise, Didier
Martinez, Carmen
Alma, Eleonora
Halaburda, Kazimierz
Sousa, Aida Botelho
Glass, Bertram
Robinson, Steven
Montoto, Silvia
Sureda, Anna

July 2022

Hodgkin lymphoma (HL) patients who relapse after autologous-stem-cell- transplantation (auto-SCT) ha...